Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
42182
CAS Number:
940310-85-0
NVP-BHG 712
Purity:
≥ 98 % (HPLC)
Synonym(s):
4-méthyl-3-[[1-méthyl-6-(3-pyridinyl)-1 H -pyrazolo[3,4-d]pyrimidin-4-yl]amino]- N -[3-(trifluorométhyl)phényl]benzamide
Hazmat
Documents
$165.65 /10 mg
Taille
Request Bulk Quote
Informations sur le produit

NVP-BHG 712 is a potent compound recognized for its significant role in pharmaceutical research, particularly in the development of targeted therapies. This compound exhibits a unique structure that allows it to interact effectively with specific biological targets, making it a valuable asset in the field of oncology and other therapeutic areas. Researchers have utilized NVP-BHG 712 in various studies to explore its efficacy against cancer cell lines, demonstrating its potential as a promising candidate for drug development. Its ability to inhibit key pathways involved in tumor growth positions it as a strong contender in the search for innovative cancer treatments.

In addition to its applications in cancer research, NVP-BHG 712's distinctive trifluoromethyl group enhances its metabolic stability and bioavailability, which are critical factors in drug design. This compound's favorable pharmacokinetic properties make it an attractive option for further investigation in clinical settings. As the pharmaceutical industry continues to seek effective and targeted therapies, NVP-BHG 712 stands out for its potential to contribute to advancements in treatment strategies, offering hope for improved patient outcomes.

Numéro CAS 
940310-85-0
Formule moléculaire
C 26 H 20 F 3 N 7 O
Poids moléculaire 
503.49
Informations générales
Numéro CAS 
940310-85-0
Formule moléculaire
C 26 H 20 F 3 N 7 O
Poids moléculaire 
503.49
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

NVP-BHG 712 is widely utilized in research focused on

  • Cancer Treatment: This compound is being explored for its potential in targeting specific cancer cells, offering a promising avenue for developing more effective therapies with fewer side effects compared to traditional treatments.
  • Drug Development: Researchers are investigating NVP-BHG 712 as a lead compound in the development of new pharmaceuticals, particularly in the field of oncology, where it may enhance the efficacy of existing drugs.
  • Biochemical Research: The compound serves as a valuable tool in biochemical studies, helping scientists understand the mechanisms of cancer cell proliferation and resistance, which is crucial for advancing treatment strategies.
  • Targeted Therapy: Its ability to selectively inhibit certain pathways in cancer cells makes it a candidate for targeted therapy, potentially leading to more personalized treatment options for patients.
  • Combination Therapies: NVP-BHG 712 is being studied in combination with other agents to evaluate synergistic effects, which could improve overall treatment outcomes and reduce the likelihood of resistance.

Citations